09:03 AM EDT, 05/13/2025 (MT Newswires) -- GE Healthcare Technologies ( GEHC ) said Tuesday it has entered into a joint development initiative with Raydiant Oximetry to progress fetal oxygen saturation monitoring technology.

The collaboration aims to integrate Raydiant Oximetry's fetal pulse oximetry technology into GE HealthCare's ( GEHC ) fetal monitoring and digital perinatal surveillance platforms, with the goal of enhancing the detection of fetal distress during childbirth, GE Healthcare ( GEHC ) said.

Terms of the agreement were not disclosed.

GE Healthcare ( GEHC ) shares were 1.1% higher in recent premarket activity.